Diversified Healthcare Trust (DHC) filed an 8-K on November 16, 2026, disclosing updated financial guidance for the full year 2026. The company provided a range for Normalized Funds From Operations (Normalized FFO) per common share of $0.46 to $0.52, down from a previous estimate of $0.56 to $0.62. The company reported a total Normalized FFO range of $110.7 million to $125.7 million and Adjusted EBITDAre of $275.7 million to $290.7 million.

The updated guidance reflects a reduction in recurring capital expenditures, which DHC estimates will decrease by $10 million to $20 million annually. The company attributes the guidance update to a reduction in the recurring capital expenditure budget for its Senior Housing Operating Portfolio (SHOP). The filing notes that the previous guidance was issued on November 2, 2026, and this update reflects the revised capital expenditure assumptions.

In addition to the financial guidance, DHC highlighted its liquidity position. As of September 30, 2026, the company reported total cash and cash equivalents of $110.7 million, along with $150 million of undrawn availability under its revolving credit facility. This brings the total near-term available liquidity to approximately $260.7 million.

The company also provided segment-specific outlooks for Same Property Net Operating Income (NOI). For the SHOP segment, DHC projects Same Property NOI of $190 million to $200 million. The Medical Office and Life Science Portfolio is expected to generate Same Property NOI of $94 million to $98 million, while the All Other segment is projected to contribute $28 million to $30 million.